Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children?
Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Meth...
Saved in:
Published in | Pediatric pulmonology Vol. 58; no. 11; pp. 3303 - 3313 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc
01.11.2023
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 8755-6863 1099-0496 1099-0496 |
DOI | 10.1002/ppul.26660 |
Cover
Loading…
Abstract | Introduction
Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.
Methods
We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.
Results
Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07).
Conclusion
We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results. |
---|---|
AbstractList | Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.INTRODUCTIONInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.METHODSWe retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD-ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD-ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD-ILD group, p = .07).RESULTSAmong 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD-ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD-ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD-ILD group, p = .07).We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD-ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results.CONCLUSIONWe confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD-ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results. IntroductionInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children.MethodsWe retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis.ResultsAmong 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07).ConclusionWe confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results. Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Methods We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Results Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07). Conclusion We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results. Abstract Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the criteria for a specific connective tissue disease (CTD). We aimed to determine whether IPAF criteria could apply to children. Methods We retrospectively studied patients with ILD and autoimmunity followed at Necker Hospital between 2008 and 2019. Children were classified according to specific CTD and IPAF criteria. The epidemiology and course of the disease were studied according to the final diagnosis. Results Among 27 patients, 6 fulfilled the criteria for IPAF and represented 4.5% of all patients with ILD during the study period. Other diagnoses included juvenile dermatomyositis (30%), overlap syndromes (19%), systemic lupus erythematosus (15%), systemic sclerosis (7%), mixed CTD (4%), and rheumatoid arthritis (4%). IPAF patients were more frequently boys versus CTD‐ILD patients (67% vs. 14%, p = .02). Two patients had severe respiratory distress that led to death for one of them. The course was favorable for the others, with a good response to steroids. The course tended to be more favorable for IPAF patients than for those with CTD‐ILD (0% lung fibrosis in the IPAF group vs. 43% in the CTD‐ILD group, p = .07). Conclusion We confirmed the existence of IPAF in children. Its prevalence was lower than in adults but comparable to that found for other pediatric series. Boys were more highly represented than in CTD‐ILD. The course was favorable for most cases. Larger and more prospective studies are needed to confirm these results. |
Author | Hadchouel, Alice Berteloot, Laureline Aoust, Laura Garcelon, Nicolas Bodemer, Christine Bader‐Meunier, Brigitte Molina, Thierry Jo Drabent, Philippe |
Author_xml | – sequence: 1 givenname: Laura surname: Aoust fullname: Aoust, Laura organization: AP‐HP, Hôpital Universitaire Necker‐Enfants Malades, Service de Pneumologie Pédiatrique, Centre de Référence pour les Maladies Respiratoires Rares de l'Enfant – sequence: 2 givenname: Laureline surname: Berteloot fullname: Berteloot, Laureline organization: AP‐HP, Service d'Imagerie Pédiatrique, Hôpital Universitaire Necker‐Enfants Malades – sequence: 3 givenname: Philippe surname: Drabent fullname: Drabent, Philippe organization: AP‐HP, Hôpitaux Universitaires Necker‐Enfants Malades et Robert Debré, Service d'Anatomie Pathologique – sequence: 4 givenname: Nicolas surname: Garcelon fullname: Garcelon, Nicolas organization: Université de Paris – sequence: 5 givenname: Christine surname: Bodemer fullname: Bodemer, Christine organization: Université Paris Cité – sequence: 6 givenname: Thierry Jo surname: Molina fullname: Molina, Thierry Jo organization: Université Paris Cité – sequence: 7 givenname: Brigitte surname: Bader‐Meunier fullname: Bader‐Meunier, Brigitte organization: Imagine Institute, INSERM U1163, Paris Cité University – sequence: 8 givenname: Alice orcidid: 0000-0001-7451-9890 surname: Hadchouel fullname: Hadchouel, Alice email: alice.hadchouel-duverge@aphp.fr organization: INSERM U1151, Institut Necker Enfants Malades |
BackLink | https://inria.hal.science/hal-04339467$$DView record in HAL |
BookMark | eNp90ctqGzEUBmARUqiTZtMnGOimLUyq2-jSTTGhuYAhXthrodFIjYKscSVNgt--cidkEUpXAun7Dzr8Z-A0jtEC8BHBSwQh_rbfT-ESM8bgCVggKGULqWSnYCF417VMMPIenOX8CGF9k2gBNttogs7ZO6_7YBsfi025-OJ1aMIUfzWDz1Zn2-g4NHoqo9_tpujL4XuzGZ91GnJzt15e12BjHnwYko0_PoB3TodsL17Oc7C9_rm5um1X9zd3V8tVayiksKXSCSkNl53FHHecm97qTguJuLGDcIwgaSnpXUfqbq7HDlJLBWSO9D3FPTkHX-a5DzqoffI7nQ5q1F7dLlfqeAcpIZIy_oSq_TzbfRp_TzYXtfPZ2BB0tOOUFRaMMsSk4JV-ekMfxynFuklVXEiOCYZVfZ2VSWPOybrXHyCojmWoYxnqbxkVwzfY-KKLH2NJ2od_R9AcefbBHv4zXK3X29Wc-QP0vZ2V |
CitedBy_id | crossref_primary_10_1002_ppul_27108 crossref_primary_10_3389_fped_2023_1307607 |
Cites_doi | 10.1016/j.jbi.2018.02.019 10.1016/j.rmed.2018.02.024 10.1016/j.semarthrit.2022.152088 10.1007/s10067-018-4111-5 10.1378/chest.10-2662 10.1080/02841850902787677 10.1186/s13023-019-1270-7 10.1007/s10067-019-04836-3 10.1111/resp.13665 10.1513/AnnalsATS.201501-064OC 10.1016/j.ejim.2021.12.021 10.1016/j.rmed.2019.03.011 10.1080/03009742.2021.1907945 10.1016/j.rmed.2016.09.002 10.1016/j.rmed.2016.10.017 10.1016/j.chest.2017.03.004 10.1016/j.autrev.2019.102451 10.1002/ppul.1950160309 10.1183/13993003.00150-2015 10.2214/AJR.18.20696 10.2214/ajr.170.3.9490955 10.1097/RHU.0000000000001847 10.1002/ppul.23178 10.1186/s12890-019-0868-9 10.1183/13993003.01565-2015 10.1016/j.rmed.2021.106566 10.1183/16000617.0177-2021 10.1164/rccm.200703-393OC 10.1111/resp.13254 10.1097/MD.0000000000018589 10.1002/ppul.22742 10.1186/s12890-017-0453-z 10.1056/NEJMoa1908681 10.3389/fmed.2019.00209 10.1089/ped.2010.0008 10.1164/rccm.201305-0923ST 10.1159/000515396 |
ContentType | Journal Article |
Copyright | 2023 The Authors. published by Wiley Periodicals LLC. 2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023 Wiley Periodicals LLC. Attribution |
Copyright_xml | – notice: 2023 The Authors. published by Wiley Periodicals LLC. – notice: 2023. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023 Wiley Periodicals LLC. – notice: Attribution |
DBID | 24P AAYXX CITATION K9. 7X8 1XC |
DOI | 10.1002/ppul.26660 |
DatabaseName | Wiley Online Library Open Access CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1099-0496 |
EndPage | 3313 |
ExternalDocumentID | oai_HAL_hal_04339467v1 10_1002_ppul_26660 PPUL26660 |
Genre | article |
GrantInformation_xml | – fundername: None |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 24P 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AITYG AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RX1 RYL SAMSI SUPJJ TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ AEEZP AEQDE AIWBW AJBDE CITATION K9. 7X8 1XC |
ID | FETCH-LOGICAL-c4040-49f899c795e272577cbea5a8917ced8f6319e43bf53002fb2f04e4806f3bb42b3 |
IEDL.DBID | 24P |
ISSN | 8755-6863 1099-0496 |
IngestDate | Fri May 09 12:25:29 EDT 2025 Fri Jul 11 03:42:02 EDT 2025 Fri Jul 25 21:50:22 EDT 2025 Tue Jul 01 05:28:03 EDT 2025 Thu Apr 24 23:13:06 EDT 2025 Sun Jul 06 04:46:08 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | Attribution-NonCommercial-NoDerivs Attribution: http://creativecommons.org/licenses/by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4040-49f899c795e272577cbea5a8917ced8f6319e43bf53002fb2f04e4806f3bb42b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-7451-9890 0000-0002-3326-2811 0000-0001-8772-0905 0000-0001-8476-8196 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26660 |
PQID | 2878972320 |
PQPubID | 1036356 |
PageCount | 0 |
ParticipantIDs | hal_primary_oai_HAL_hal_04339467v1 proquest_miscellaneous_2864616987 proquest_journals_2878972320 crossref_primary_10_1002_ppul_26660 crossref_citationtrail_10_1002_ppul_26660 wiley_primary_10_1002_ppul_26660_PPUL26660 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | November 2023 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: November 2023 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken |
PublicationTitle | Pediatric pulmonology |
PublicationYear | 2023 |
Publisher | Wiley Subscription Services, Inc Wiley |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: Wiley |
References | 2015; 12 2013; 48 2019; 6 2015; 50 2022; 51 2020; 39 2013; 188 2018; 80 2019; 19 2020; 15 2017; 152 2021; 100 2020; 99 2021; 187 2018; 23 2021; 30 2019; 381 2022; 28 2020; 19 2015; 46 2010; 23 1998; 170 1993; 16 2016; 119 2017; 17 2009; 50 2007; 176 2018; 137 2022; 57 2019; 212 2020; 25 2022; 97 2017; 123 2011; 140 2019; 150 2016; 47 2018; 37 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_38_1 e_1_2_10_8_1 e_1_2_10_14_1 e_1_2_10_37_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_36_1 e_1_2_10_12_1 e_1_2_10_35_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_34_1 e_1_2_10_10_1 e_1_2_10_33_1 e_1_2_10_11_1 e_1_2_10_32_1 e_1_2_10_31_1 e_1_2_10_30_1 e_1_2_10_29_1 e_1_2_10_27_1 e_1_2_10_28_1 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 17 issue: 1 year: 2017 article-title: Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features publication-title: BMC Pulm Med – volume: 23 start-page: 33 issue: 1 year: 2010 end-page: 41 article-title: Interstitial lung disease in children older than 2 years publication-title: Pediatr Allergy Immunol Pulmonol – volume: 37 start-page: 2125 issue: 8 year: 2018 end-page: 2132 article-title: Clinical features, risk factors, and outcomes of patients with interstitial pneumonia with autoimmune features: a population‐based study publication-title: Clin Rheumatol – volume: 19 issue: 2 year: 2020 article-title: Interstitial pneumonia with autoimmune features: a single center prospective follow‐up study publication-title: Autoimmun Rev – volume: 187 year: 2021 article-title: Clinical spectrum of children with interstitial pneumonia with autoimmune features publication-title: Respir Med – volume: 15 year: 2020 article-title: Etiologic spectrum of interstitial lung diseases in Chinese children older than 2 years of age publication-title: Orphanet J Rare Dis – volume: 51 start-page: 34 issue: 1 year: 2022 end-page: 41 article-title: Rheumatological evaluation of patients with interstitial lung disease publication-title: Scand J Rheumatol – volume: 100 start-page: 853 issue: 9 year: 2021 end-page: 864 article-title: Baseline characteristics and survival of an Australian interstitial pneumonia with autoimmune features cohort publication-title: Respiration – volume: 28 start-page: 257 issue: 5 year: 2022 end-page: 264 article-title: Identification and prognosis of patients with interstitial pneumonia with autoimmune features publication-title: J Clin Rheumatol – volume: 25 start-page: 636 issue: 6 year: 2020 end-page: 643 article-title: Long‐term clinical course and outcome of interstitial pneumonia with autoimmune features publication-title: Respirology – volume: 46 start-page: 976 issue: 4 year: 2015 end-page: 987 article-title: An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features publication-title: Eur Respir J – volume: 123 start-page: 56 year: 2017 end-page: 62 article-title: Interstitial pneumonia with autoimmune features: clinical, radiologic, and histological characteristics and outcome in a series of 57 patients publication-title: Respir Med – volume: 50 start-page: 1159 issue: 12 year: 2015 end-page: 1169 article-title: Sex and the lung: observations, hypotheses, and future directions: sex and the lung publication-title: Pediatr Pulmonol – volume: 57 year: 2022 article-title: The role of myositis‐specific autoantibodies and the management of interstitial lung disease in idiopathic inflammatory myopathies: a systematic review publication-title: Semin Arthritis Rheum – volume: 188 start-page: 376 issue: 3 year: 2013 end-page: 394 article-title: An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy publication-title: Am J Respir Crit Care Med – volume: 119 start-page: 150 year: 2016 end-page: 154 article-title: Clinical features and natural history of interstitial pneumonia with autoimmune features: a single center experience publication-title: Respir Med – volume: 16 start-page: 184 issue: 3 year: 1993 end-page: 196 article-title: Chronic interstitial lung disease in children publication-title: Pediatr Pulmonol – volume: 19 issue: 1 year: 2019 article-title: Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis publication-title: BMC Pulm Med – volume: 152 start-page: 103 issue: 1 year: 2017 end-page: 112 article-title: Idiopathic interstitial pneumonia associated with autoantibodies publication-title: Chest – volume: 99 issue: 4 year: 2020 article-title: Impact of a systematic evaluation of connective tissue disease on diagnosis approach in patients with interstitial lung diseases publication-title: Medicine – volume: 39 start-page: 575 issue: 2 year: 2020 end-page: 583 article-title: Comparative analysis of connective tissue disease‐associated interstitial lung disease and interstitial pneumonia with autoimmune features publication-title: Clin Rheumatol – volume: 381 start-page: 1718 issue: 18 year: 2019 end-page: 1727 article-title: Nintedanib in progressive fibrosing interstitial lung diseases publication-title: N Engl J Med – volume: 140 start-page: 1292 issue: 5 year: 2011 end-page: 1299 article-title: Autoimmune‐featured interstitial lung disease publication-title: Chest – volume: 48 start-page: 1016 issue: 10 year: 2013 end-page: 1025 article-title: The lung is involved in juvenile dermatomyositis publication-title: Pediatr Pulmonol – volume: 212 start-page: 1 year: 2019 end-page: 10 article-title: Childhood interstitial (Diffuse) lung disease: pattern recognition approach to diagnosis in infants publication-title: Am J Roentgenol – volume: 6 year: 2019 article-title: Interstitial pneumonia with autoimmune features (IPAF) publication-title: Front Med – volume: 170 start-page: 691 issue: 3 year: 1998 end-page: 697 article-title: Systemic sclerosis: using high‐resolution CT to detect lung disease in children publication-title: Am J Roentgenol – volume: 80 start-page: 52 year: 2018 end-page: 63 article-title: A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse publication-title: J Biomed Inf – volume: 50 start-page: 430 issue: 4 year: 2009 end-page: 436 article-title: Chest abnormalities in juvenile‐onset mixed connective tissue disease: assessment with high‐resolution computed tomography and pulmonary function tests publication-title: Acta Radiol – volume: 23 start-page: 600 issue: 6 year: 2018 end-page: 605 article-title: Overlap of interstitial pneumonia with autoimmune features with undifferentiated connective tissue disease and contribution of UIP to mortality publication-title: Respirology – volume: 150 start-page: 154 year: 2019 end-page: 160 article-title: Clinical, serological and radiological features of a prospective cohort of interstitial pneumonia with autoimmune features (IPAF) patients publication-title: Respir Med – volume: 12 start-page: 1498 issue: 10 year: 2015 end-page: 1505 article-title: Diffuse lung disease in biopsied children 2 to 18 years of age. application of the chILD classification scheme publication-title: Ann Am Thorac Soc – volume: 30 issue: 162 year: 2021 article-title: Interstitial pneumonia with autoimmune features: challenges and controversies publication-title: Eur Respir Rev – volume: 137 start-page: 167 year: 2018 end-page: 175 article-title: Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia publication-title: Respir Med – volume: 47 start-page: 1767 issue: 6 year: 2016 end-page: 1775 article-title: Characterisation of patients with interstitial pneumonia with autoimmune features publication-title: Eur Respir J – volume: 176 start-page: 1120 issue: 11 year: 2007 end-page: 1128 article-title: Diffuse lung disease in young children: application of a novel classification scheme publication-title: Am J Respir Crit Care Med – volume: 97 start-page: 62 year: 2022 end-page: 68 article-title: Interstitial pneumonia with autoimmune features: evaluation of connective tissue disease incidence during follow‐up publication-title: Eur J Intern Med – ident: e_1_2_10_26_1 doi: 10.1016/j.jbi.2018.02.019 – ident: e_1_2_10_13_1 doi: 10.1016/j.rmed.2018.02.024 – ident: e_1_2_10_38_1 doi: 10.1016/j.semarthrit.2022.152088 – ident: e_1_2_10_12_1 doi: 10.1007/s10067-018-4111-5 – ident: e_1_2_10_32_1 doi: 10.1378/chest.10-2662 – ident: e_1_2_10_35_1 doi: 10.1080/02841850902787677 – ident: e_1_2_10_24_1 doi: 10.1186/s13023-019-1270-7 – ident: e_1_2_10_17_1 doi: 10.1007/s10067-019-04836-3 – ident: e_1_2_10_20_1 doi: 10.1111/resp.13665 – ident: e_1_2_10_5_1 doi: 10.1513/AnnalsATS.201501-064OC – ident: e_1_2_10_22_1 doi: 10.1016/j.ejim.2021.12.021 – ident: e_1_2_10_16_1 doi: 10.1016/j.rmed.2019.03.011 – ident: e_1_2_10_31_1 doi: 10.1080/03009742.2021.1907945 – ident: e_1_2_10_9_1 doi: 10.1016/j.rmed.2016.09.002 – ident: e_1_2_10_10_1 doi: 10.1016/j.rmed.2016.10.017 – ident: e_1_2_10_19_1 doi: 10.1016/j.chest.2017.03.004 – ident: e_1_2_10_21_1 doi: 10.1016/j.autrev.2019.102451 – ident: e_1_2_10_27_1 doi: 10.1002/ppul.1950160309 – ident: e_1_2_10_6_1 doi: 10.1183/13993003.00150-2015 – ident: e_1_2_10_2_1 doi: 10.2214/AJR.18.20696 – ident: e_1_2_10_37_1 doi: 10.2214/ajr.170.3.9490955 – ident: e_1_2_10_18_1 doi: 10.1097/RHU.0000000000001847 – ident: e_1_2_10_30_1 doi: 10.1002/ppul.23178 – ident: e_1_2_10_15_1 doi: 10.1186/s12890-019-0868-9 – ident: e_1_2_10_8_1 doi: 10.1183/13993003.01565-2015 – ident: e_1_2_10_25_1 doi: 10.1016/j.rmed.2021.106566 – ident: e_1_2_10_23_1 doi: 10.1183/16000617.0177-2021 – ident: e_1_2_10_3_1 doi: 10.1164/rccm.200703-393OC – ident: e_1_2_10_14_1 doi: 10.1111/resp.13254 – ident: e_1_2_10_33_1 doi: 10.1097/MD.0000000000018589 – ident: e_1_2_10_34_1 doi: 10.1002/ppul.22742 – ident: e_1_2_10_11_1 doi: 10.1186/s12890-017-0453-z – ident: e_1_2_10_28_1 doi: 10.1056/NEJMoa1908681 – ident: e_1_2_10_29_1 doi: 10.3389/fmed.2019.00209 – ident: e_1_2_10_36_1 doi: 10.1089/ped.2010.0008 – ident: e_1_2_10_4_1 doi: 10.1164/rccm.201305-0923ST – ident: e_1_2_10_7_1 doi: 10.1159/000515396 |
SSID | ssj0009991 |
Score | 2.4048703 |
Snippet | Introduction
Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do... IntroductionInterstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not... Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity who do not meet the... Abstract Introduction Interstitial pneumonia with autoimmune features (IPAF) has been defined for adults with interstitial lung disease (ILD) and autoimmunity... |
SourceID | hal proquest crossref wiley |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 3303 |
SubjectTerms | autoimmunity children connective tissue disease Human health and pathology intersitial lung disease Life Sciences Lung diseases |
Title | Unclassifiable interstitial lung disease and autoimmunity: Towards IPAF in children? |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26660 https://www.proquest.com/docview/2878972320 https://www.proquest.com/docview/2864616987 https://inria.hal.science/hal-04339467 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3rS8MwEA8-QPwiPnG-iI8vCtUtTdNGBBnqmKIyZAO_lSRLcDC64TbB_967tOsURPBLKe2ltJdcc5fL73eEnEjDjTWSBQqC5IA7IQLNVC3oKvCXVWxiV0Nw8tOzaHb4w2v0OkeupliYnB-iXHBDy_D_azRwpUcXM9LQ4XDSP4fpRUDAvojYWhzljLdmlLvS18sDhzwKRCLCkpyUXcza_piO5t9wM-Q3T_O7v-onnMYqWSk8RVrPu3aNzNlsnSw9FbnwDdLuZAZd357rIfyJIvHDO2b-YUTRPtgwLZIvVGVdqibjQc9jQcafl7TtN8uO6H2r3oCGdArpvt4kncZd-6YZFDUSAsNxMyCXDiImE8vIshjMLzbaqkglEIUZ202cABOzPNQuCuHDnWauyi1PqsKFWnOmwy2ykA0yu00oxHqSOSlixyMueFcnxlhcG2FRCJpyFXI6VVVqCgJxrGPRT3PqY5aiWlOv1go5LmWHOW3Gr1JHoPFSAJmum_XHFK8hr5qEn_hHrUL2ph2SFvY1SiHOS7BeGoNnHJa3wTIw3aEyO5igjOCiJmQSV8iZ78g_XiVttTqP_mznP8K7ZBnrz-fgxD2yMH6f2H3wUsb6wA9GON6-sC8ireJr |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dSyMxEA9-gN6LnF9Y9c748aKwarPZ7OZejiKWqq30oQXfQpImXKFsi7aC_70z2e1WQYR7W3Yny-4kk8znbwg5k5ZbZyWLNBjJEfdCRIbpejTQoC_r1Ka-jsXJnUfR6vP7p-SpzM3BWpgCH6JyuKFkhP0aBRwd0lcL1NDJZDa6hPNFgMW-ygVLsXMD490F5q4MDfNAI08ikYm4QidlV4uxn86j5X-YDflB1fyosIYTp_mTbJSqIm0Uc7tJlly-RdY6ZTB8m_T6uUXdd-iHWP9EEfnhGUP_sKToCISYltEXqvMB1bPpeBiKQaZvf2gvZMu-0LtuowkD6bym--8O6TdvezetqGySEFmO2YBcejCZbCoTx1KQv9QapxOdgRlm3SDzAmTM8dj4JIYf94b5a-54di18bAxnJt4lK_k4d3uEgrEnmZci9Tzhgg9MZq1D5whLYuCUr5HzOauULRHEsZHFSBXYx0whW1Vga42cVrSTAjfjS6oT4HhFgFDXrUZb4T0EVpOwi7_Wa-RwPiGqFLAXBYZehg3TGLzjuHoMooHxDp278QxpBBd1IbO0Ri7CRH7zKarb7bfD1f7_EB-R9Vav01btu8eHA_IDm9EXlYqHZGX6PHO_QGWZmt9hYb4DDIPk7g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9swED-6DspeRvfFsrab9vGygddGlmVrDEbYFtItLX5IoG9CkiUaCE5ok0L_-97JjtPBGOzN2Cdjn3TS73S63wF8UE447xRPDDrJiQhSJpabflIZxMsmd3noU3Ly2bkcTcWvi-xiB75ucmEafohuw40sI87XZODLKhxvSUOXy_X8My4vEh32hxTto_HNRbml3FWxXh4C8iyRhUw7clJ-vG37x3L04JIOQ95DmvfxalxwhvvwuEWKbNB07RPY8fVT2DtrY-HPYDKtHUHfWZhR-hMj4ocrivzjiGJztGHWBl-YqStm1qvFLOaCrG6_sEk8LHvNTsvBEBuyTUr3t-cwHf6cfB8lbY2ExAk6DChUQI_J5SrzPEfzy531JjMFemHOV0WQaGJepDZkKf54sDycCC-KExlSawW36QvYrRe1fwkMfT3Fg5J5EJmQorKFc572RniWoqZCDz5uVKVdSyBOdSzmuqE-5prUqqNae_C-k102tBl_lXqHGu8EiOl6NBhruke8agon8Zt-Dw43HaJb-7rW6OcVVC-N4zvedo_RMijcYWq_WJOMFLIvVZH34FPsyH98ii7L6Thevfof4TewV_4Y6vHp-e8DeESl6Js8xUPYXV2t_REClpV9HcflHc0E5CA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Unclassifiable+interstitial+lung+disease+and+autoimmunity%3A+Towards+IPAF+in+children%3F&rft.jtitle=Pediatric+pulmonology&rft.au=Aoust%2C+Laura&rft.au=Berteloot%2C+Laureline&rft.au=Drabent%2C+Philippe&rft.au=Garcelon%2C+Nicolas&rft.date=2023-11-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=8755-6863&rft.eissn=1099-0496&rft.volume=58&rft.issue=11&rft.spage=3303&rft.epage=3313&rft_id=info:doi/10.1002%2Fppul.26660&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8755-6863&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8755-6863&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8755-6863&client=summon |